Pharmaceuticals, Biotechnology and Life Sciences
CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #AMD—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies…
CVL-231 has the potential to be the first novel mechanism of action in schizophrenia in over two decades BOSTON–(BUSINESS WIRE)–Cerevel…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, a biotechnology company focused on drugging the human immune synapse to treat human diseases, today announced…
Top line results are expected to be available in February 2020 GAINESVILLE, Fla.–(BUSINESS WIRE)–Cyclo Therapeutics, Inc. (OTCQB: CTDH), formerly CTD…
More than $2.9 million in funding will support clinical trials to study virtual reality platforms as a therapeutic alternative for…
LONDON–(BUSINESS WIRE)–#MarketIntelligence–SpendEdge, a global procurement market intelligence firm, has announced the release of its Global Pharmaceutical Excipients Market – Procurement…
WESTPORT, Conn.–(BUSINESS WIRE)–Intensity Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary intratumoral immunotherapy products to kill tumors and increase immune…
First gene therapy for patients 12 years and older with transfusion-dependent β-thalassemia who do not have a β0/β0 genotype now…
NEW YORK–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform clinical-stage gene therapy company, today announces the clearance…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oncorus, Inc., a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today announced…